Rhenman & Partners Asset Management AB
Position in MEDP — Medpace Holdings, Inc.
CIK 1599882
Stockholm, V7
Position in MEDP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,501,515
+$3,343,693 QoQ
Shares Held
8,500
+123.7% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#184
of 692 holders
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $92,380,973 across 7 Diagnostics & Research names. MEDP ranks #7 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
115,000 | $17,253,450 | |
| 2 | NTRA |
Natera, Inc.
|
61,050 | $16,572,022 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
31,580 | $15,832,948 | |
| 4 | DHR |
Danaher Corp /De/
|
80,252 | $15,286,400 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
57,200 | $12,972,388 | |
| 6 | A |
Agilent Technologies, Inc.
|
75,000 | $9,962,250 | |
| 7 | MEDP |
Medpace Holdings, Inc.
This page
|
8,500 | $4,501,515 |
All Filings in MEDP
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,501,515 | 8,500 | Shares | Sole | 2026-08-13 | |
| 2025-03-31 | $1,157,822 | 3,800 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,259,164 | 6,800 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,503,500 | 7,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,029,625 | 2,500 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||